Want to see ECIA full AI Analyst Report?
ECIA Stock Chart & Stats
$0.19
$0.03(7.14%)
At close: 4:00 PM EST
$0.19
$0.03(7.14%)
Day’s Range― - ―
52-Week Range$0.03 - $0.39
Previous CloseN/A
Volume5.10K
Average Volume (3M)2.06K
Market Cap
$685.31K
Enterprise Value$1.42
Total Cash (Recent Filing)$170.76K
Total Debt (Recent Filing)$1.56M
Price to Earnings (P/E)―
Beta23.51
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding16,879,644
10 Day Avg. Volume270
30 Day Avg. Volume2,055
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.35
Price to Sales (P/S)0.33
P/FCF Ratio-4.53
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Disposable-product RevenueSales of disposable components create a usage-driven revenue model linked to procedure volumes, allowing repeat purchases rather than relying solely on large, infrequent equipment orders. This structure can support customer continuity and recurring demand when surgical activity remains stable.
Healthy Gross MarginA gross margin near 47% indicates the products continue to generate meaningful profit after direct costs, suggesting the core offering retains economic value. If revenue stabilizes, this margin provides a foundation for improving operating leverage and moving the company toward sustainable profitability.
Positive Equity BaseMaintaining positive equity and relatively stable assets provides some balance-sheet support despite current losses and leverage pressure. This financial base may preserve flexibility for continued operations and product investment over the next several months, provided cash outflows do not worsen.
Bears Say
Persistent Revenue DeclineSeveral years of shrinking revenue, including another decline of about 8% in the latest period, indicate weakening commercial momentum rather than a temporary fluctuation. Continued contraction can reduce scale, limit investment capacity, and make it harder for fixed costs to be absorbed.
Operating And Net LossesNegative operating and net margins show that the current revenue base is insufficient to cover the company’s broader cost structure, despite healthy gross margin. Sustained losses can erode equity, constrain product development, and make a durable return to profitability dependent on cost reduction or renewed growth.
Negative Cash GenerationNegative operating and free cash flow means the business is not currently self-funding, even after accounting for operating activity and investment needs. Persistent cash burn increases reliance on financing or balance-sheet resources and reduces flexibility to withstand continued revenue weakness.
Encision News
ECIA FAQ
What was Encision Inc’s price range in the past 12 months?
Encision Inc lowest stock price was $0.03 and its highest was $0.39 in the past 12 months.
What is Encision Inc’s market cap?
Encision Inc’s market cap is $685.31K.
When is Encision Inc’s upcoming earnings report date?
Encision Inc’s upcoming earnings report date is Nov 18, 2026 which is in 68 days.
How were Encision Inc’s earnings last quarter?
Encision Inc released its earnings results on Aug 11, 2026. The company reported $0.001 earnings per share for the quarter.
Is Encision Inc overvalued?
According to Wall Street analysts Encision Inc’s price is currently Overvalued.
Does Encision Inc pay dividends?
Encision Inc does not currently pay dividends.
What is Encision Inc’s EPS estimate?
Encision Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Encision Inc have?
Encision Inc has 16,879,644 shares outstanding.
What happened to Encision Inc’s price movement after its last earnings report?
Encision Inc reported an EPS of $0.001 in its last earnings report. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Encision Inc?
Currently, no hedge funds are holding shares in ECIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Encision Inc
Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.
Technical Analysis
Ownership Overview
16.79% Insiders
6.29% Other Institutional Investors
76.92% Public Companies and
Individual Investors